Study Finds Cannabis Compounds Effective in Preventing COVID-19
by Gary Miller
The Government of Canada is investing an additional $25.8M in research to continue global efforts to address the COVID-19 outbreak. This investment is just a small portion of the $275M in funding for research on medical countermeasures against COVID-19 announced by the Canadian Prime Minister on March 11, 2020. Cannalogue, a healthcare technology company that had received Health Canada’s first direct-to-sales license for medical cannabis – is seeking approval for clinical trials in a cannabis-based treatment for COVID-19.
Scientists have long investigated the immunomodulatory properties of cannabis. Some research suggests that THC and other cannabinoids are immune-suppressants — other studies, however, suggest that cannabis can boost the immune system by increasing white blood cell count in patients with immunodeficiency disorders such as HIV. Cannalogue is conducting a research study and hoping for a clinical trial in response to the call from Prime Minister Justin Trudeau for all Canadian businesses and innovators to stand united in the fight against coronavirus.
The specialists at Cannalogue believe the active medical ingredients from the cannabis plant could potentially boost the immune system to reduce the severity of symptoms from coronavirus. The trial is intended to assess if medical cannabis could mitigate the symptoms caused by COVID-19 infection or any mutant coronavirus strains. The company has launched a website for volunteers to apply in the event the clinical trial is approved by Health Canada.
Dr. Mohan Cooray, president and CEO of Cannalogue and a specialist in Internal Medicine, Gastroenterology, and Hepatology, said that while the company is “not suggesting with current knowledge of medical cannabis that it is a prevention, treatment or cure” of the disease, “plant cannabinoids have naturally occurring immunomodulatory properties that absolutely require expedited investigation given the current global COVID-19 pandemic.”
Clinical trials are conducted to investigate whether the use of a drug is safe and effective, what dosages are most effective, and what side effects may be associated with the use of the drug. Clinical trials require the informed consent of patients and enable the healthcare community to systematically collect information about the risks and benefits of the treatment. Health Canada is working to fast-track COVID-19 related clinical trials.
Cannalogue’s theory is if cannabinoid receptors are stimulated before infection, they may dampen the inflammatory response that follows, which is a key factor in the severity of symptoms observed in patients. Currently, there are no therapies available for either the prevention or treatment of COVID-19. While certain products may alleviate COVID-19 symptoms, such as fever and cough, there are no proven treatments to prevent or cure.
Health Canada is closely tracking all potential therapeutic treatments and vaccines in development in Canada and abroad, including products that are being used off-label. Cannalogue said that in support of the medical cannabis sector and scientific research community, it will release an exclusive insider health report that reveals key medical insights on emerging therapeutic areas with respect to medical cannabis.
The flowering buds of the cannabis plant have always been the star of the show due to their high concentration of cannabinoids like THC and CBD that create effects for consumers. But what many don’t know is that other parts of the plant—specifically the trim removed after harvesting—can be used for a variety of purposes….
Thinking about magic mushrooms takes me back to my teenage years when we would pick liberty caps from farmers’ fields. Liberty caps offered a great free buzz at the time in my life when I started to understand these substances to be a mind-expanding one as well. What started out as fun and giggles eventually…
Can you imagine what it is like to be overcome with intense feelings of euphoria? In the midst of all the madness caused by the motions of life, you take a pill and suddenly everything is brighter, more magical, and just feels so darn good? It turns out that this blissful drug, MDMA, has the…
Many states across the U.S. have legalized cannabis for medical and retail consumption. The regulations governing these industries primarily focus on the products’ content of the two most prominent cannabinoids found in the cannabis plant, cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). But in recent months, a new cannabinoid known as delta-8-tetrahydrocannabinol (delta-8 THC) has entered the…
Cannabis contains many cannabinoids that interact with the body’s endocannabinoid system (ECS), which we still have much to learn about. The most well-known cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD), but there are many others that are equally beneficial. One of these is cannabinol (CBN), dubbed “the sleepy cannabinoid” due to its potential as a…
Since Nov. 8, prime brokerage clients affiliated with JPMorgan Chase & Co. have been unable to purchase some cannabis-associated securities. The news,…
Cannabis should be legalized, regulated, and taxed like many other profitable commodities in South Dakota, according to the state legislature. Residential voters…
The Assembly of First Nations (AFN) is asking Canada’s federal government to eradicate regulatory restrictions present in the Cannabis Act, that are…
